z-logo
open-access-imgOpen Access
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice
Author(s) -
Stefania Momi,
Giuseppe Guglielmini,
Giulia Ciarroca Taranta,
Elisa Giglio,
Angela Monopoli,
Paolo Gresele
Publication year - 2022
Publication title -
bleeding thrombosis and vascular biology
Language(s) - English
Resource type - Journals
ISSN - 2785-5309
DOI - 10.4081/btvb.2022.19
Subject(s) - pravastatin , ldl receptor , medicine , chemistry , endocrinology , nitric oxide , platelet , cholesterol , lipoprotein

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom